Hormonal therapies for menstrual migraine

Current Pain and Headache Reports

Volumn 13, Issue 5, 2009, Pages 381-385

  Calhoun, Anne H ^a   Hutchinson, Susan ^a  

^a Carolina Headache Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; CONTRACEPTIVE AGENT; DESOGESTREL PLUS ETHINYLESTRADIOL; DROSPIRENONE PLUS ETHINYLESTRADIOL; ESTRADIOL; ESTROGEN; ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS ETONOGESTREL; ETHINYLESTRADIOL PLUS LEVONORGESTREL; ETHINYLESTRADIOL PLUS NORELGESTROMIN; ETHINYLESTRADIOL PLUS NORETHISTERONE ACETATE; ETONOGESTREL; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT; PLACEBO;

AMENORRHEA; BREAKTHROUGH BLEEDING; BREAST TENDERNESS; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DEPRESSION; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG MEGADOSE; DRUG USE; FLUID RETENTION; GEL; HORMONAL THERAPY; HUMAN; LOW DRUG DOSE; MENOPAUSAL SYNDROME; MENSTRUAL MIGRAINE; MIGRAINE AURA; MIGRAINE WITHOUT AURA; MOOD DISORDER; NAUSEA; ORAL CONTRACEPTION; REVIEW; RISK FACTOR; SIDE EFFECT; SMOKING; SPOTTING; TRANSDERMAL PATCH; TREATMENT FAILURE; VAGINA RING;

CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVES, ORAL, HORMONAL; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; MENSTRUATION; MIGRAINE DISORDERS; PREMENSTRUAL SYNDROME;

EID: 70349638305     PISSN: 15313433     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11916-009-0062-5     Document Type: Review

References (21)

1. Lipton RB, Stewart WF, Diamond S, et al.: Prevalence and burden of migraine in the United States: Data from the American Migraine Study II. Headache 2001, 41:646-657.
2. Lay CL, MascelDino AM: Menstrual migraine: diagnosis and treatment. Curr Pain Headache Rep 2001, 5:195-199.
3. Mannix LK, Calhoun AH: Menstrual migraine. Curr Treat Options Neurol 2004, 6:489-498.
4. Martin VT, Wernke S, Mandell K, et al.: Defining the relationship between ovarian hormones and migraine headache. Headache 2005, 45:1190-1201.
5. Courturier EG, Bombof MA, Neven AK, van Duijn NP: Menstrual migraine in a representative Dutch population sample: Prevalence, disability and treatment. Cephalalgia 2003, 23:302-308.
6. Calhoun A: Four hypotheses for understanding menstrual migraine. Female Patient 2004, 29:38-44.
7. Calhoun AH: A novel specific prophylaxis for menstrual-associated migraine. South Med J 2004, 97:819-822.
8. Calhoun A, Ford S: Elimination of menstrual-related migraine beneficially impacts chronification and medication overuse. Headache 2008, 48:1186-1193.
9. Sulak P, Willis S, Kuehl T, et al.: Headaches and oral contraceptives: impact of eliminating the standard 7-day placebo interval. Headache 2007, 47:27-37.
10. Archer DF: Menstrual-cycle-rAlated symptoms: a review of the rationale for continuous use of oral contraceptives. Contraception 2006, 74:359-366.
11. Ischaemic stroke and combined oral contraceptives: Results of an international, multicentre, case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Lancet 1996, 348:498-505.
12. Chan WS, Ray J, Wai EK, et al.: Risk of stroke in women exposed to low-dose oral contraceptives: A critical evaluation of the evidence. Arch Intern Med 2004, 164:741-747.
13. Etminan M, Takkouche B, Isorna FC, Samii A: Risk of ischaemic stroke in people with migraine: Systematic review and meta-analysis of observational studies. BMJ 2005, 330:63.
14. Petitti DB, Sidney S, Bernstein A, et al.: Stroke in users of low-dose oral contraceptives. N Engl J Med 1996, 335:8-15.
15. Schwartz SM, Petitti DB, Siscovick DS, et al.: Stroke and use of low-dose oral contraceptives in young women: A pooled analysis of two US studies. Stroke 1998, 29:2277-2284.
16. Donaghy M, Chang CL, Poulter N: Duration, frequency, recency, and type of migraine and the risk of ischaemic stroke in women of childbearing age. J Neurol Neurosurg Psychiatry 2002, 73:747-750.
17. MacClellan LR, Giles W, Cole J, et al.: Probable migraine with visual aura and risk of ischemic stroke: The stroke prevention in young women study. Stroke 2007, 38:2438-2445.
18. de Lignieres B, Vincens M, Mauvais-Jarvis P, et al.: Prevention of menstrual migraine by percutaneous oestradiol. Br Med J (Clin Res Ed) 1986, 293:1540.
19. Dennerstein L,AMorse C, Burrows G, et al.: Menstrual migraine: a double-blind trial of percutaneous estradiol. Gynecol Endocrinol 1988, 2:113-120.
20. MacGregor EA, Frith A, Ellis J, et al.: Prevention of menstrual attacks of migraine: A double-blind placebo-controlled crossover study. Neurology 2006, 67:2159-2163.
21. Smits MG, van der Meer YG, Pfeil JP, et al.: Perimenstrual migraine: effect of Estraderm TTS and the value of contingent negative variation and exteroceptive temporalis muscle suppression test. Headache 1994, 34:103-106.